Brenntag (BNR) Q3 2025 earnings summary

Executive summary

• Q3 2025 sales were EUR 3.7bn, down 4.7% year-over-year, with operating EBITDA at EUR 330m, and EBITA at EUR 243m, both declining year-over-year.

• The planned split into two divisions was halted, maintaining both Essentials and Specialties within one group to leverage synergies and scale.

• Strategic focus shifted to sales growth, organizational simplification, and execution of cost-out programs, with a new governance structure and executive committee.

• Cost containment program delivered EUR 45 million in Q3 savings, with acceleration planned and a target of EUR 300 million annual savings by 2027.

• Strategic review initiated, with results expected in the second half of 2026.

Financial highlights

• Operating gross profit for Q3 2025 was EUR 947 million, down 3.1% year-over-year, with a margin of 25.5%.

• Operating expenses totaled EUR 617 million, a 1% net decline year-over-year on a constant currency basis.

• Operating EBITDA was EUR 330 million, down 6.7% year-over-year; operating EBITA was EUR 243 million, down 9.2%.

• Free cash flow for Q3 2025 was EUR 315.6 million, up 27.9% year-over-year, driven by strong working capital management and lower capex.

• Earnings per share were EUR 0.78, slightly lower than the previous year.

Outlook and guidance

• Full-year 2025 operating EBITA guidance specified at the lower end of EUR 950 million–1,050 million.

• Continued economic uncertainty, geopolitical tensions, and global tariff issues expected to persist into Q4 2025 and beyond.

• Cost containment, organizational simplification, and sales execution remain key focus areas.

• CAPEX for 2025 is forecast at around EUR 200 million, down from previous guidance.

• Tax rate guidance for 2025 is 35-37% due to one-time effects, with an underlying rate of 28-30%.